Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China
· Delayed Price · Currency is CNY 13.32
-0.13 (-0.97%)
Apr 29, 2026, 3:04 PM CST
SHE:002675 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 2,652 | 2,713 | 2,846 | 3,267 | 3,565 | 3,897 | Upgrade
|
| Other Revenue | 28.05 | 28.05 | 23.35 | 8.24 | 18.34 | 15.02 | Upgrade
|
| Revenue | 2,681 | 2,741 | 2,869 | 3,276 | 3,583 | 3,912 | Upgrade
|
| Revenue Growth (YoY) | -7.84% | -4.46% | -12.42% | -8.58% | -8.41% | 14.42% | Upgrade
|
| Cost of Revenue | 1,274 | 1,356 | 1,521 | 1,922 | 2,051 | 2,324 | Upgrade
|
| Gross Profit | 1,406 | 1,385 | 1,348 | 1,354 | 1,532 | 1,588 | Upgrade
|
| Selling, General & Admin | 748.46 | 745.12 | 724.93 | 754.41 | 785.29 | 802.41 | Upgrade
|
| Research & Development | 230.61 | 232.61 | 291.91 | 197.22 | 163.52 | 137.56 | Upgrade
|
| Other Operating Expenses | 43.97 | 40.71 | 31.76 | 33.87 | 29.19 | 33.34 | Upgrade
|
| Operating Expenses | 1,025 | 1,033 | 1,065 | 980.31 | 980.56 | 974.77 | Upgrade
|
| Operating Income | 380.88 | 352.17 | 282.61 | 373.77 | 551.72 | 612.99 | Upgrade
|
| Interest Expense | -146.28 | -137.54 | -96.51 | -56.76 | -58.64 | -56.45 | Upgrade
|
| Interest & Investment Income | 6.97 | 5.17 | 5.56 | 12.78 | 13.2 | 5.12 | Upgrade
|
| Currency Exchange Gain (Loss) | -13.23 | -13.23 | 15.44 | 15.25 | 42.65 | -4.08 | Upgrade
|
| Other Non Operating Income (Expenses) | -11.9 | -2.23 | -2.79 | -1.17 | -5.94 | -2.58 | Upgrade
|
| EBT Excluding Unusual Items | 216.44 | 204.34 | 204.31 | 343.86 | 542.97 | 555 | Upgrade
|
| Impairment of Goodwill | - | - | -52.6 | - | -80.1 | -211.26 | Upgrade
|
| Gain (Loss) on Sale of Investments | -14.44 | -15.88 | -12.92 | -28.13 | -39.21 | -12.15 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.31 | -0.33 | 0.21 | -0.23 | -0.38 | -0.15 | Upgrade
|
| Asset Writedown | - | - | -33.21 | - | - | -0.16 | Upgrade
|
| Other Unusual Items | 23.3 | 23.3 | 113.31 | 21.77 | 22.3 | 24.82 | Upgrade
|
| Pretax Income | 225 | 211.44 | 219.1 | 337.28 | 445.58 | 356.1 | Upgrade
|
| Income Tax Expense | 52.84 | 57 | 77.68 | 83.07 | 92.75 | 95.25 | Upgrade
|
| Earnings From Continuing Operations | 172.16 | 154.44 | 141.43 | 254.22 | 352.83 | 260.85 | Upgrade
|
| Minority Interest in Earnings | 32.17 | 41.19 | 42.4 | -44.48 | -45.54 | -109.29 | Upgrade
|
| Net Income | 204.33 | 195.63 | 183.83 | 209.74 | 307.29 | 151.56 | Upgrade
|
| Net Income to Common | 204.33 | 195.63 | 183.83 | 209.74 | 307.29 | 151.56 | Upgrade
|
| Net Income Growth | 41.67% | 6.42% | -12.35% | -31.75% | 102.75% | -63.72% | Upgrade
|
| Shares Outstanding (Basic) | 825 | 825 | 825 | 825 | 808 | 802 | Upgrade
|
| Shares Outstanding (Diluted) | 825 | 825 | 825 | 825 | 808 | 802 | Upgrade
|
| Shares Change (YoY) | 0.05% | 0.01% | -0.01% | 2.10% | 0.68% | 0.01% | Upgrade
|
| EPS (Basic) | 0.25 | 0.24 | 0.22 | 0.25 | 0.38 | 0.19 | Upgrade
|
| EPS (Diluted) | 0.25 | 0.24 | 0.22 | 0.25 | 0.38 | 0.19 | Upgrade
|
| EPS Growth | 41.60% | 6.42% | -12.35% | -33.15% | 101.38% | -63.73% | Upgrade
|
| Free Cash Flow | 73.13 | 219.03 | -168.94 | -235 | 606.93 | 413.42 | Upgrade
|
| Free Cash Flow Per Share | 0.09 | 0.27 | -0.20 | -0.28 | 0.75 | 0.52 | Upgrade
|
| Dividend Per Share | 0.081 | 0.081 | 0.080 | 0.125 | 0.150 | 0.150 | Upgrade
|
| Dividend Growth | 0.78% | 0.78% | -36.00% | -16.67% | - | -40.00% | Upgrade
|
| Gross Margin | 52.46% | 50.52% | 46.97% | 41.34% | 42.77% | 40.59% | Upgrade
|
| Operating Margin | 14.21% | 12.85% | 9.85% | 11.41% | 15.40% | 15.67% | Upgrade
|
| Profit Margin | 7.62% | 7.14% | 6.41% | 6.40% | 8.58% | 3.87% | Upgrade
|
| Free Cash Flow Margin | 2.73% | 7.99% | -5.89% | -7.17% | 16.94% | 10.57% | Upgrade
|
| EBITDA | 565.38 | 530.64 | 436.95 | 511.69 | 672.09 | 727.92 | Upgrade
|
| EBITDA Margin | 21.09% | 19.36% | 15.23% | 15.62% | 18.76% | 18.61% | Upgrade
|
| D&A For EBITDA | 184.51 | 178.47 | 154.34 | 137.92 | 120.37 | 114.93 | Upgrade
|
| EBIT | 380.88 | 352.17 | 282.61 | 373.77 | 551.72 | 612.99 | Upgrade
|
| EBIT Margin | 14.21% | 12.85% | 9.85% | 11.41% | 15.40% | 15.67% | Upgrade
|
| Effective Tax Rate | 23.48% | 26.96% | 35.45% | 24.63% | 20.82% | 26.75% | Upgrade
|
| Revenue as Reported | 2,681 | 2,741 | 2,869 | 3,276 | 3,583 | 3,912 | Upgrade
|
| Advertising Expenses | - | 0.42 | 0.5 | 1.06 | 0.83 | 0.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.